Codexis (CDXS) Net Margin Growth (3y) (2013 - 2026)
Codexis (CDXS) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 9,283.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Codexis | 135.70 Mn | 70.56 Mn | 13.18 Mn | 11,714.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,714.00 |
| Dec 31, 2025 | 8,833.00 |
| Sep 30, 2025 | -19,907.00 |
| Jun 30, 2025 | -7,971.00 |
| Mar 31, 2025 | -25,062.00 |
| Dec 31, 2024 | -676.00 |
| Sep 30, 2024 | -16,694.00 |
| Jun 30, 2024 | -26,843.00 |
| Mar 31, 2024 | -1,710.00 |
| Dec 31, 2023 | -12,520.00 |
| Sep 30, 2023 | -34,314.00 |
| Jun 30, 2023 | -18,807.00 |
| Mar 31, 2023 | -12,206.00 |
| Dec 31, 2022 | -6,025.00 |
| Sep 30, 2022 | -3,055.00 |
| Jun 30, 2022 | 4,595.00 |
| Mar 31, 2022 | 931.00 |
| Dec 31, 2021 | -3,872.00 |
| Sep 30, 2021 | 1,783.00 |
| Jun 30, 2021 | 1,083.00 |